#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Non-small cell lung cancer metastatic Asthma Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Neuropathy peripheral Palmoplantar pustulosis Cystic fibrosis gastrointestinal disease Exudative retinopathy Hereditary hypophosphataemic rickets Congenital pseudarthrosis Retinal dystrophy Proteus syndrome Interstitial lung disease Neovascular age-related macular degeneration Isodicentric chromosome 15 syndrome Ocular lymphoma Hidradenitis Brain stem glioma Juvenile chronic myelomonocytic leukaemia More trials…

    Learn about Rare Diseases

    Congenital generalised lipodystrophy – Basic Information Myxofibrosarcoma – Diagnostics Pleural mesothelioma malignant – Diagnostics Turner’s syndrome – Diagnostics Haemophilia B with anti factor IX – Basic Information Testicular leiomyosarcoma Haemophagocytic lymphohistiocytosis – Basic Information Epidermolysis bullosa – Diagnostics Testicular leiomyosarcoma – Trials in Disease Noonan syndrome – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Intestifix Calcium Carbonate Midomafetamine Hydrochloride Mometasone Furoate Monohydrate Fludarabine Phosphate Plitidepsin Ict01 Regn7257 Jk08 Tyrosine Levomethadone Hydrochloride Naloxegol Oxalate Florbetapir (18F) Dexamethasone Acetate Dmd06-Mab Atl001 Danicopan Phleum Pratense Pollen Extract Pf-06835375 Etidronate Disodium More therapies…

    Learn about Your Condition

    Neurodevelopmental disorder Atrial fibrillation Metastatic neoplasm Deafness traumatic Neuropathic arthropathy Uveitis Micrographic skin surgery Postoperative wound infection Colorectal cancer stage III Intervertebral disc protrusion Sinusitis bacterial Coronary artery disease Endometrial cancer stage IV Pustular psoriasis Cirrhosis alcoholic More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Pneumologisches Forschungsinstitut Hohegeest GbR

Pneumologisches Forschungsinstitut Hohegeest GbR

Bohnenstr. 1, Geesthacht, 21502, Germany

Want to learn more about this study or check if you can participate? Contact us.

  • A study testing GSK3862995B compared to placebo for safety and effectiveness in adults aged 18 to 85 years with bronchiectasis

    Recruiting

    2 1
    Investigated Diseases:
    • Bronchiectasis
    Investigated Drugs:
    • GSK3862995B
    Denmark France Germany Italy Poland Spain

  • Study on the Effectiveness and Safety of Taplucainium Inhalation Powder (NOC-110) for Adults with Refractory or Unexplained Chronic Cough

    Not recruiting

    2 1
    Investigated Drugs:
    • Taplucainium Chloride
    Belgium Germany Poland

  • Study on the Effectiveness and Safety of Camlipixant for Adults with Refractory or Unexplained Chronic Cough

    Not recruiting

    3 1
    Investigated Drugs:
    • Camlipixant
    Czechia Germany Poland Slovakia

  • Study on the Effectiveness and Safety of Budesonide, Glycopyrronium, and Formoterol Inhaler for Adults and Adolescents with Severe Asthma

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Asthma
    Investigated Drugs:
    • Formoterol Fumarate
    • Formoterol Fumarate Dihydrate
    • Budesonide
    Czechia Germany Greece Portugal Slovakia

  • Study Comparing Depemokimab, Mepolizumab, and Benralizumab for Adults and Adolescents with Severe Eosinophilic Asthma

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Depemokimab
    • Mepolizumab
    • Benralizumab
    Austria Finland France Germany Ireland Italy +6

  • Study on the Effectiveness of PURETHAL Mites for Adults with Moderate to Severe Allergic Rhinitis or Rhinoconjunctivitis Due to House Dust Mite Allergy

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Conjunctivitis allergic
    • Rhinitis allergic
    Investigated Drugs:
    • Agrostis Stolonifera Pollen
    • Alnus Glutinosa Pollen
    • Aluminium Hydroxide
    Austria Bulgaria Germany Latvia Lithuania Poland

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!